Publication date: Sep 04, 2019
I’ve read plenty about age discrimination when it comes to qualifying for clinical trials, pharmaceutical initiatives, studies, and surveys. The Elderly Need Not Apply” confirmed my suspicions about age discrimination in healthcare. Older age groups, the ones who would benefit the most from various studies, are shut out of trials. How can doctors properly care for older patients when there’s no evidence on which to base advice? I recently listened to a discussion about doctors not recommending disease-modifying therapy (DMT) for older patients. That said, according to a Medscape article titled, -Safe to Stop MS Disease-Modifying Therapy After Age 60?” This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. The opinions expressed in this column are not those of Multiple Sclerosis News Today or its parent company, BioNews Services, and are intended to spark discussion about issues pertaining to multiple sclerosis.
- Are Your MS Disease-modifying Treatments Old School or New School?
- Need to Know: How a Spinal Tap Can Help to Diagnose MS
- Neurological reserve: How the brain can adapt to MS damage Sponsored Post
- The Clinical Trial I Participated in Was a Positive Experience
- MS Progression’s Speed Tagged to ‘Smoldering’ Brain Inflammation